Physician profile
Jared Blum
NPI 1740800242
$12,786.01
in general payments reported to CMS, 2019-2025
26 companies · $1,531 in 2025
The $1,531 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $26.98 · 2021: $2,570 · 2022: $1,790 · 2023: $2,972 · 2024: $3,896 · 2025: $1,531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,279 · Travel and Lodging: $4,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,278.94 |
| Travel and Lodging | $4,119.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,734.12 | 2021-2025 | Prostep, Variax, Citrefix |
| Medical Device Business Services, INC. | $2,346.39 | 2024 | |
| Medinc of Texas | $1,307.21 | 2021-2022 | |
| Liberty Surgical INC. | $1,200.00 | 2021 | |
| Treace Medical Concepts, INC. | $701.70 | 2023-2025 | |
| Depuy Synthes Sales INC. | $648.74 | 2024 | Motoband, Hammerlock |
| Paragon 28, INC. | $496.12 | 2023 | Portfolio |
| Integra Lifesciences Corporation | $473.46 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acera Surgical, INC. | $272.28 | 2025 | Restrata Wound Matrix |
| Axogen | $240.24 | 2022-2023 | Avance Nerve Graft |
| Smith+Nephew, INC. | $236.63 | 2021-2025 | Evos, Grafix Pl, Collagenase Santyl |
| Amgen INC. | $188.86 | 2024-2025 | Krystexxa |
| Bard Peripheral Vascular, INC. | $149.99 | 2024 | Rotarexs 6 F X 135 Cm |
| Royal Biologics, INC. | $135.00 | 2024 | |
| Convatec INC. | $133.97 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $121.92 | 2023 | Nuzyra |
| Penumbra, INC. | $116.05 | 2025 | Penumbra System |
| Kerecis Limited | $47.25 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Bioventus LLC | $44.83 | 2025 | Exogen Ultrasound Bone Healing System |
| Osteomed LLC | $42.80 | 2022 | |
| Ossdsign USA Incorporated | $40.56 | 2024 | |
| Zimmer Biomet Holdings, INC. | $26.98 | 2020 | |
| Mimedx Group, INC. | $23.31 | 2025 | |
| Saluda Medical Americas, INC. | $21.40 | 2025 | Evoke |
| Urgo Medical North America, LLC | $18.13 | 2025 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Organogenesis INC. | $18.07 | 2025 | Affinity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Blum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.